IGC Pharma, Inc. (AMEX: IGC) last traded at $0.308, up 11.11% on the session. The quote above updates while this page is open; the figures below are drawn from IGC Pharma, Inc.’s own filings and are restated only when a new one is published.
IGC Pharma, Inc. trades on AMEX under the ticker IGC. Its market capitalisation is $31.84 million.
Valuation measures for IGC Pharma, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $31.84M |
|---|---|
| Enterprise value | $34.88M |
| Price / sales | 25.05 |
| Price / book | 5.19 |
| Beta | 0.88 |
Trailing-twelve-month figures tagged in IGC Pharma, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $1.27M |
|---|---|
| Net income (TTM) | -$7.12M |
| EPS (TTM) | -$0.0900 |
| Gross margin | 48.70% |
| Operating margin | -585.84% |
| Return on equity | -116.14% |
| Cash | $331.0K |
Range and volume for IGC over the past 52 weeks.
| 52-week high | $0.500 |
|---|---|
| 52-week low | $0.240 |
| Volume | 1.85M |
| Average volume | 674.1K |
| Previous close | $0.277 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.